Zhejiang DiAn Diagnostics Co - Asset Resilience Ratio

Latest as of March 2026: 3.61%

Zhejiang DiAn Diagnostics Co (300244) has an Asset Resilience Ratio of 3.61% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Zhejiang DiAn Diagnostics Co PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥508.66 Million

≈ $74.43 Million USD Cash + Short-term Investments

Total Assets

CN¥14.08 Billion

≈ $2.06 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Zhejiang DiAn Diagnostics Co's Asset Resilience Ratio has changed over time. See how leveraged is Zhejiang DiAn Diagnostics Co's balance sheet to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang DiAn Diagnostics Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Zhejiang DiAn Diagnostics Co (300244) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥508.66 Million	3.61%
Total Liquid Assets	CN¥508.66 Million	3.61%

Asset Resilience Insights

Limited Liquidity: Zhejiang DiAn Diagnostics Co maintains only 3.61% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Zhejiang DiAn Diagnostics Co Industry Peers by Asset Resilience Ratio

Compare Zhejiang DiAn Diagnostics Co's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Fleury S.A. SA:FLRY3	Diagnostics & Research	16.06%
Wuhan Thalys Med Tech Co Ltd SHG:603716	Diagnostics & Research	0.12%
Spectral Med Inc TO:EDT	Diagnostics & Research	11.67%
Bcal Diagnostics Ltd AU:BDX	Diagnostics & Research	0.00%
Genetic Signatures Ltd AU:GSS	Diagnostics & Research	60.91%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%

Annual Asset Resilience Ratio for Zhejiang DiAn Diagnostics Co (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Zhejiang DiAn Diagnostics Co.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	3.08%	CN¥444.45 Million ≈ $65.04 Million	CN¥14.42 Billion ≈ $2.11 Billion	+0.65pp
2024-12-31	2.44%	CN¥384.59 Million ≈ $56.28 Million	CN¥15.79 Billion ≈ $2.31 Billion	+0.10pp
2023-12-31	2.33%	CN¥418.30 Million ≈ $61.21 Million	CN¥17.94 Billion ≈ $2.63 Billion	+0.19pp
2022-12-31	2.14%	CN¥450.09 Million ≈ $65.86 Million	CN¥21.06 Billion ≈ $3.08 Billion	-0.60pp
2021-12-31	2.74%	CN¥427.22 Million ≈ $62.52 Million	CN¥15.59 Billion ≈ $2.28 Billion	+0.24pp
2020-12-31	2.50%	CN¥310.26 Million ≈ $45.40 Million	CN¥12.40 Billion ≈ $1.81 Billion	-0.23pp
2019-12-31	2.73%	CN¥293.24 Million ≈ $42.91 Million	CN¥10.75 Billion ≈ $1.57 Billion	--

pp = percentage points

About Zhejiang DiAn Diagnostics Co

SHE:300244 China Diagnostics & Research

Market Cap

$1.67 Billion

CN¥11.40 Billion CNY

Market Cap Rank

#6944 Global

#1561 in China

Share Price

CN¥18.24

Change (1 day)

+0.39%

52-Week Range

CN¥13.59 - CN¥29.50

All Time High

CN¥46.17